banner2

Getting started
3′-Nitro Acetophenone

3′-Nitro Acetophenone - Factory, Suppliers, Manufacturers from China

3′-Nitro Acetophenone, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

3'-Nitroacetophenone CAS 121-89-1 Purity 99.0 (HPLC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 3'-Nitroacetophenone CAS 121-89-1 Purity >99.0% (HPLC)
Read More

2'-Chloroacetophenone CAS 2142-68-9 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 2'-Chloroacetophenone CAS 2142-68-9 Purity ≥99.0% (GC)

2-Aminoacetophenone Hydrochloride CAS 5468-37-1 Purity 98.5 (HPLC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 2-Aminoacetophenone Hydrochloride CAS 5468-37-1 Purity >98.5% (HPLC)

2',4'-Dichloroacetophenone CAS 2234-16-4 Purity 98.0 (HPLC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 2',4'-Dichloroacetophenone CAS 2234-16-4 Purity >99.0% (HPLC)

4'-Dimethylaminoacetophenone CAS 2124-31-4 Purity 98.0 (HPLC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 4'-Dimethylaminoacetophenone CAS 2124-31-4 Purity >98.0% (HPLC)

3'-Bromoacetophenone CAS 2142-63-4 Purity 99.0 (GC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 3'-Bromoacetophenone CAS 2142-63-4 Purity >99.0% (GC)

4'-Benzyloxyacetophenone CAS 54696-05-8 Purity 99.0 (HPLC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 4'-Benzyloxyacetophenone CAS 54696-05-8 Purity >99.0% (HPLC)

banner1

Top Selling Products

Related Blog
Reviews

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
Yellow phosphorus and phosphoric acid rose together

Yellow phosphorus and phosphoric acid rose together Yunnan-guizhou yellow phosphorus prices rose.Data show that the offer of 34500 yuan/ton at the beginning of the week has risen to 60,000 yuan/to...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021)-Shanghai Ruifu Chemical Co., Ltd. participated in the exhibition

The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021) was held on September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. Adhering to...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...

2022.08.16 03:13:25
2022.08.03 21:56:35
2022.07.03 14:49:57
2022.07.01 16:51:14
2022.01.21 01:48:54
2021.11.22 02:08:11

related search